Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes

被引:0
|
作者
Arnush, M [1 ]
Scarim, AL [1 ]
Heitmeier, MR [1 ]
Kelly, CB [1 ]
Corbett, JA [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 160卷 / 06期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purpose of this study was to evaluate the effects of resident islet macrophage activation on beta cell function, Treatment of freshly isolated rat islets with TNF-alpha and LPS results in a potent inhibition of glucose-stimulated insulin secretion. The inhibitory actions of TNF + LPS are mediated by the intraislet production and release of IL-1 followed by IL-1-induced inducible nitric oxide synthase (iNOS) expression by beta cells, The IL-1R antagonist protein completely prevents TNF + LPS-induced nitrite production, iNOS expression and the inhibitory effects on glucose-stimulated insulin secretion by rat islets, Resident macrophages appear to be the source of IL-1, as a 7-day culture of rat islets at 24 degrees C (conditions known to deplete islets of lymphoid cells) prevents TNF + LPS-induced iNOS expression, nitrite production, and the inhibitory effects on insulin secretion, In addition, macrophage depletion also inhibits TNF + LPS-induced IL-1 alpha and IL-1 beta mRNA expression in rat islets, Immunocytochemical colocalization of IL-1 beta with the macrophage-specific marker ED1 was used to provide direct support for resident macrophages as the islet cellular source of IL-1, IL-1 beta appears to mediate the inhibitory actions of TNF + LPS on beta cell function as TNF + LPS-induced expression of IL-1 beta is fourfold higher than IL-1 alpha, and Ab neutralization of IL-1 beta prevents TNF + LPS-induced nitrite production by rat islets, These findings support a mechanism by which the activation of resident islet macrophages and the intraislet release of IL-1 may mediate the initial dysfunction and destruction of beta cells during the development of autoimmune diabetes.
引用
收藏
页码:2684 / 2691
页数:8
相关论文
共 50 条
  • [41] Role of Heparanase in Macrophage Activation
    Elkin, Michael
    HEPARANASE: FROM BASIC RESEARCH TO CLINICAL APPLICATIONS, 2020, 1221 : 445 - 460
  • [42] ISLET TRANSPLANTATION TO STUDY AUTOIMMUNE PATHOGENESIS OF DIABETES IN BB RAT
    MARKMANN, JF
    WOEHRLE, M
    ROZA, A
    BARKER, CF
    NAJI, A
    HORMONE AND METABOLIC RESEARCH, 1990, 25 : 116 - 119
  • [43] Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes
    Hinke, Simon A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 788 - 804
  • [44] Population dynamics of islet-infiltrating cells in autoimmune diabetes
    Magnuson, Angela M.
    Thurber, Greg M.
    Kohler, Rainer H.
    Weissleder, Ralph
    Mathis, Diane
    Benoist, Christophe
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (05) : 1511 - 1516
  • [45] IMMUNOLOGICAL CONSEQUENCES OF ISLET MHC ANTIGEN MODULATION IN AUTOIMMUNE DIABETES
    MARKMANN, JF
    POSSELT, AM
    LEVY, M
    NAJI, A
    BARKER, CF
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (02) : 849 - 850
  • [46] The search for the mechanism of early sympathetic islet neuropathy in autoimmune diabetes
    Taborsky, G. J., Jr.
    Mei, Q.
    Hackney, D. J.
    Mundinger, T. O.
    DIABETES OBESITY & METABOLISM, 2014, 16 : 96 - 101
  • [47] Islet regeneration during the reversal of autoimmune diabetes in NOD mice
    Kodama, S
    Kühtreiber, W
    Fujimura, S
    Dale, EA
    Faustman, DL
    SCIENCE, 2003, 302 (5648) : 1223 - 1227
  • [48] New Onset Autoimmune Disease or Macrophage Activation Syndrome?
    Greene, J. Palmer
    Wild, Bridget M.
    PEDIATRIC ANNALS, 2019, 48 (10): : E395 - E399
  • [49] NEOPTERIN IN AUTOIMMUNE NEUROLOGICAL DISEASES - A MARKER OF MACROPHAGE ACTIVATION
    PROVENZANO, C
    BARTOCCIONI, E
    CITTADINI, A
    SAMBO, A
    GIANNATTASIO, B
    BATOCCHI, AP
    JOURNAL OF NEUROIMMUNOLOGY, 1987, 16 (01) : 142 - 142
  • [50] The role of Fas in autoimmune diabetes
    Chervonsky, AV
    Wang, Y
    Wong, FS
    Visintin, I
    Flavell, RA
    Janeway, CA
    Matis, LA
    CELL, 1997, 89 (01) : 17 - 24